• Increase font size
  • Default font size
  • Decrease font size

Flu Stocks

PDF Print E-mail
By Staff and Wire Reports   

Companies with Certified Existing Treatments for Swine Flu

Gilead Sciences, Inc. (NASDAQ:GILD)
Roche Holding Ltd. (OTC:RHHBY)
Product: Tamiflu (oseltamivir)

GlaxoSmithKline plc (NYSE:GSK) /
Biota Holdings Ltd.(ASX:BTA)
Product: Relenza (zanamivir)

Baxter International Inc. (NYSE: BAX)
Product:
A(H1N1) vaccine using its Vero cell culture technology

Novartis AG (NYSE:NVS)
Product: Influenza A(H1N1) vaccine using Cell-based manufacturing technology

Companies with Potential Treatments for Swine Flu

CEL-SCI Corporation (Amex: CVM)
Product: proprietary L.E.A.P.S. technology (Ligand Epitope Antigen Presentation System)

Companies with Potential Vaccines
for Swine Flu


Biota Holdings Ltd.(ASX:BTA) /
Daiichi Sankyo
Product: CS-8958

BioCryst Pharmaceuticals,Inc. (NASDAQ:BCRX)
Product: Peramivir Intravenous

Novavax, Inc. (NASDAQ:NVAX)
Product: Swine Flu Vaccines
using Virus-like particle (VLP) technology

Inovio Biomedical Corporation (NYSE Amex:INO)
Product: SynCon™ H1N1 influenza DNA vaccines


Vical Incorporated(Public, NASDAQ:VICL)
Product:
Patented DNA delivery technology

Sinovac Biotech Ltd. (Amex: SVA)
Product: Panflu(TM)

Wyeth (NYSE: WYE)
Product: PCV13 or Prevnar 13

MedImmune / AstraZeneca PLC (NYSE:AZN)
Product: needle-free, nasal spray swine flu vaccine by using Live Attenuated Influenza Vaccine (LAIV) technology

Sanofi-Aventis SA (NYSE:SNY)
Product: Swine Flu Vaccine

Companies with Adjuvants
for Swine Flu Vaccines

Antigenics, Inc. (NASDAQ:AGEN)
Product: QS-21 Stimulon

Hemispherx Biopharma (AMEX:HEB)
Product: Ampligen

Other Technologies
Which Combat H1N1

Oculus Innovative Sciences, Inc.
(NASDAQ:OCLS)
Microcyn® Technology platform



BiomedReports is not paid or compensated to report news and developments about publicly traded companies. Full disclosure can be read in the About Us Section

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus
 
about 6 hours ago Illumina’s Board Unanimously Rejects Roche’s Offer; Shire Announces FDA Approval of Vyvanse®: Below is a look at... http://t.co/L3FZivQV
about 15 hours ago Achillion ($ACHN) hammered after BofA rates to "Underperform" citing no M&A speculation. What we said last month: http://t.co/usWk95O6
about 1 day ago Medgenics ($MDGN) up 10% on Monday! We first told you about the firm last Friday: http://t.co/aD50CMSH
about 1 day ago Thinly traded BioLineRx shares move on hepatitis C deal: The shares of thinly traded BioLineRx (NASDAQ:BLRX) soa... http://t.co/ugbuZgNN
about 1 day ago Orexigen® Announces Agreement From the FDA on a Special Protocol Assessment; Acorda Announces Launch of Generic ... http://t.co/vSt6VrLP
about 1 day ago $CVM up 17% and technically looks like it may head higher.
about 1 day ago $ANAC drops after GlaxoSmithKline (GSK) pauses enrollment for its clinical trials of its urinary tract infection drug. http://t.co/yUUSzkUr
about 1 day ago Catalysts on tap for Corcept: Corcept Therapeutics (NASDAQ:CORT) is a drug discovery company focused on the deve... http://t.co/jd3C1ddH

navigation

Free Phone Trade Alerts